SCHEMBL22891219

SCHEMBL22891219

C=CC(=O)OCCCCOc1ccc(C(=O)Oc2ccc(OC(=O)c3ccc(OCCCCOC(C)=O)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ THRB P10828 1/20 0.49
▸ NFKB1 P19838 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ PRSS1 P07477 1/20 0.46
▸ ACR P10323 1/20 0.46
▸ HTT P42858 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13197222 0.95 NPC1 (0.49) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL16379523 0.95 NPC1 (0.49) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL21113772 0.95 NPC1 (0.49) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL13922519 0.94 NPC1 (0.50) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL13572566 0.94 NPC1 (0.50) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL12768595 0.94 NPC1 (0.50) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL13572558 0.94 NPC1 (0.50) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL13220816 0.93 THRB (0.55) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL12794252 0.93 THRB (0.55) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL450098 0.93 THRB (0.55) NPC1LMNACYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11860338-B2 Optical film FUJIFILM CORPORATION (JP) 2024-01-02 — — US disclosed
US-20220171096-A1 OPTICAL FILM FUJIFILM CORPORATION (JP) 2022-06-02 — — US disclosed
US-20210198230-A1 COMPOUND, COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM FUJIFILM CORPORATION (JP) 2021-07-01 — — US disclosed
US-20210008916-A1 IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2021-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198230-A1 COMPOUND, COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM HTR1A, TPH1, HTR1B NPC1 2155/4885LMNA 2220/4885CYP3A4 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback